Detection of possible undiagnosed cases of diabetes in customers at a community pharmacy

Authors

  • JL ARIAS Departamento de Farmacia y Tecnología Farmacéutica. Facultad de Farmacia. Universidad de Granada, 18071 Granada (Granada). España.
  • F LINARES-MOLINERO Oficina de Farmacia Santamaría. C/ Periodista José María Carulla nº 8, 18014 Granada (Granada). España.
  • JM SANTAMARÍA-LÓPEZ Oficina de Farmacia Santamaría. C/ Periodista José María Carulla nº 8, 18014 Granada (Granada). España.

Keywords:

Community Pharmacy, Diabetes Mellitus, Health Education, Undiagnosed Diabetes, Pharmaceutical Care, Screening

Abstract

As part of a localised health care initiative, a campaign for the detection of possible undiagnosed cases of diabeteswas carried out from the 28th of March to the 28th of June 2005, at a local community pharmacy, giving good resultsand a high level of acceptance from pharmacy customers. The diabetes risk test proposed by the American DiabetesAssociation (ADA) was used in the selection process of persons for blood glucose testing under conditions of previousfasting (8-10 hrs). The ADA test is based on a points scoring system, in which a score of 10 points is considered ascause for recommendation for blood glucose testing. The methodology used for the determination of blood glucoselevels in this research was that based on colorimetric reactions. In the ADA test, 53.0% of cases scored ten points orover, while 36.4% of blood glucose determinations resulted in levels equal to or over 110 mg/dL, thus indicating theusefulness of this tool for the purposes of research. Persons with such high levels of blood glucose were referred to aphysician for analysis.

Downloads

Download data is not yet available.

References

Lasheras Aldaz B. Diabetes mellitus y fármacos antidiabéticos. En: Consejo General de Colegios Oficiales de Farmacéuticos. Editor. Avances en Farmacología y Farmacoterapia, Módulo IV: Avances en Endocrinología. Madrid: Acción Médica, S. A.; 2003. p. 57-82.

American Diabetes Association. Report of committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.

World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation, Geneva, 1999.

De Pablos Velasco PI, Martínez Martín FJ, Rodríguez-Pérez F, Ania BJ, Losada A, Betancor P. Prevalence and determinants of diabetes mellitus and glucose intolerance in canarian caucasian population. Comparison of the ADA and the 1985 WHO criteria. The guia study. Diabetic Med 2001; 18: 235-241.

Soriguer-Escofet F, Esteva I, Rojo-Martínez G, Ruiz-de-Adana S, Catala M, Merelo MJ, et al. Prevalence of latent autoinmune diabetes of adults (LADA) in southern Spain. Diabetes Res Clin Pract 2002; 56: 213-220.

Consejería de Salud de la Junta de Andalucía. Andalucía: Plan integral de diabetes (2003-2007). 10º Ed. Sevilla: Consejería

de Salud; 2003.

Jiménez FJ, Monsanto HA. Screening, monitoring and educating patients with diabetes in an independent community pharmacy in Puerto Rico. P R Health Sci J 2001; 1: 35-39.

Guerra García MM, Fornos Pérez JA, Andrés Rodríguez NF. Detección de diabéticos no diagnosticados en las farmacias

comunitarias de la provincia de Pontevedra. Pharm Care Esp 2003; 5: 166-169.

López Sánchez S. Diabetes mellitus. En: Bonal de Falgás J. Editor. Farmacia Clínica. Madrid: Síntesis, S. A.; 1999. p. 167-188.

Barbería Layana JJ, Muñoz Hornillos M, Yoldi Bienzobas G, Zazpe García I. Diabetes mellitus. En: Muñoz Hornillos M, Aranceta Bartrina J, García-Jalón de la Lama I. Editores. Nutrición aplicada y dietoterapia. Pamplona: Ediciones Universidad de Navarra, S. A. (EUNSA); 1999. p. 285-320.

American Diabetes Association. Clinical Practice Recommendations 2000. Screening for Type-2 Diabetes. Diabetes Care 2000; 23 Suppl. 1.

Sociedad Española para el estudio de la Obesidad. Consenso SEEDO´2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc) 2000; 115: 587-597.

Pérez Unauna MªP, Alonso Sacristán P, Roiz Fernández JC, García Lázaro MªI. Diabetes tipo II: ¿Qué podemos esperar tras la adopción de los nuevos criterios diagnósticos? Incremento de la prevalencia de diabetes y diagnóstico precoz en la población atendida en un centro de salud. Medifam 2002; 12(3): 49-60.

Lebovitz HE. Diagnóstico y clasificación de la diabetes mellitus. En: Lebovitz HE. Editor. Tratamiento de la diabetes mellitus y sus complicaciones. 3º Ed. Barcelona: American Diabetes Association; 1998. p. 5-7.

Artola S, López A. Prevención de la diabetes. Jano Emc 2001; 60(1372): 39-45.

Sanz Granda A. Detección de la diabetes mellitus. Acofar 2001; (395): 8-9.

Published

2007-04-20

How to Cite

1.
ARIAS J, LINARES-MOLINERO F, SANTAMARÍA-LÓPEZ J. Detection of possible undiagnosed cases of diabetes in customers at a community pharmacy. Ars Pharm [Internet]. 2007 Apr. 20 [cited 2024 Jul. 22];48(2):187-200. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/4985

Issue

Section

Original Articles